Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1915-1916

  Marra, Alexandre R ^a,b   Major, Yvette ^a   Edmond, Michael B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b A D Williams Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DALFOPRISTIN; GENTAMICIN; IMIPENEM; LINEZOLID; PIPERACILLIN PLUS TAZOBACTAM; QUINUPRISTIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CASE REPORT; CENTRAL VENOUS CATHETER; CHRONIC LUNG DISEASE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE COURSE; ENTEROCOCCUS FAECALIS; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL;

ACETAMIDES; AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; CATHETERIZATION, CENTRAL VENOUS; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; OXAZOLIDINONES; VANCOMYCIN;

ENTEROCOCCUS FAECALIS;

EID: 33646595631     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1915-1916.2006     Document Type: Article

References (11)

1. Baysallar, M., A. Kilic, H. Aydogan, F. Cilli, and L. Doganci. 2004. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey. Int. J. Antimicrob. Agents 23:510-512.
2. Boo, T. W., R. Hone, G. Sheehan, and M. Walsh. 2003. Isolation of linezolid-resistant Enterococcus faecalis. J. Hosp. Infect. 53:312-314.
3. Burleson, B. S., D. J. Ritchie, S. T. Micek, and W. M. Dunne. 2004. Enterococcus faecalis resistant to linezolid: case series and review of the literature. Pharmacotherapy 24:1225-1231.
4. Dibo, I., S. K. Pillai, H. S. Gold, M. R. Baer, M. Wetzler, J. L. Slack, P. A. Hazamy, D. Ball, C. B. Hsiao, P. L. McCarthy Juniorperiod, and B. H. Segal. 2004. Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient. J. Clin. Microbiol. 42:1843-1845.
5. Gonzales, R. D., P. C. Schreckenberger, M. B. Graham, S. Kelkar, K. DenBesten, and J. P. Quinn. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357:1179.
6. Hancock, R. E. 2005. Mechanisms of action of newer antibiotics for gram-positive pathogens. Lancet Infect. Dis. 5:209-218.
7. Johnson, A. P., L. Tysall, M. V. Stockdale, N. Woodford, M. E. Kaufmann, M. Warner, D. M. Livermore, F. Asboth, and F. J. Allerberger. 2002. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit. Eur. J. Clin. Microbiol. Infect. Dis. 21:751-754.
8. LeClercq, R., E. Erlot, J. Duval, and P. Courvalin. 1988. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319:157-161.
9. Prystowsky, J., F. Siddiqui, J. Chosay, D. L. Shinabarger, J. Millichap, L. R. Peterson, and G. A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45:2154-2156.
10. Ross, J. E., T. R. Anderegg, H. S. Sader, T. R. Fritsche, and R. N. Jones. 2005. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox annual appraisal of potency and spectrum program. Diagn. Microbiol. Infect. Dis. 52:53-58.
11. Singh, K. V., G. M. Weinstock, and B. E. Murray. 2002. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob. Agents Chemother. 46:1845-1850.